149 related articles for article (PubMed ID: 38436679)
1. Tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis of randomized and non-randomized studies.
Ma Y; Xiang H; Busse JW; Yao M; Guo J; Ge L; Li B; Luo X; Mei F; Liu J; Wang Y; Liu Y; Li W; Zou K; Li L; Sun X
J Neurol; 2024 May; 271(5):2309-2323. PubMed ID: 38436679
[TBL] [Abstract][Full Text] [Related]
2. Tenecteplase versus alteplase for patients with acute ischemic stroke: a meta-analysis of randomized controlled trials.
Zhang X; Wan TF; Chen J; Liu L
Aging (Albany NY); 2023 Dec; 15(24):14889-14899. PubMed ID: 38149983
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration.
Warach SJ; Ranta A; Kim J; Song SS; Wallace A; Beharry J; Gibson D; Cadilhac DA; Bladin CF; Kleinig TJ; Harvey J; Palanikumar L; Doss VT; Marescalco R; Fink JN; Tyson A; Schlick KH; Noh L; Wilson D; Figueroa S; Pech MA; Paletz LB; Lewis MK; Castro M; Sahlein DH; Lafranchise EF; Sandall J; Asif KS; Geraghty SR; Cullis PA; Malisch T; Neill TA; LaMonte MP; Campbell BCV; Wu TY
JAMA Neurol; 2023 Jul; 80(7):732-738. PubMed ID: 37252708
[TBL] [Abstract][Full Text] [Related]
4. Functional Outcome and Hemorrhage Rates After Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core.
Gerschenfeld G; Turc G; Obadia M; Chausson N; Consoli A; Olindo S; Caroff J; Marnat G; Blanc R; Ben Hassen W; Seners P; Guillon B; Wiener E; Bourcier R; Yger M; Cho TH; Checkouri T; Gory B; Smadja D; Sibon I; Richard S; Piotin M; Eker OF; Pico F; Lapergue B; Alamowitch S;
Neurology; 2024 Jul; 103(1):e209398. PubMed ID: 38862134
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
Wang L; Hao M; Wu N; Wu S; Fisher M; Xiong Y
J Am Heart Assoc; 2024 May; 13(9):e031692. PubMed ID: 38686848
[TBL] [Abstract][Full Text] [Related]
6. Reteplase versus Alteplase for Acute Ischemic Stroke.
Li S; Gu HQ; Li H; Wang X; Jin A; Guo S; Lu G; Che F; Wang W; Wei Y; Wang Y; Li Z; Meng X; Zhao X; Liu L; Wang Y;
N Engl J Med; 2024 Jun; 390(24):2264-2273. PubMed ID: 38884332
[TBL] [Abstract][Full Text] [Related]
7. Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB; Ankolekar S; Appireddy R; Arenillas JF; Assis Z; Bailey P; Barber PA; Bazan R; Buck BH; Butcher KS; Camden MC; Campbell BCV; Casaubon LK; Catanese L; Chatterjee K; Choi PMC; Clarke B; Dowlatshahi D; Ferrari J; Field TS; Ganesh A; Ghia D; Goyal M; Greisenegger S; Halse O; Horn M; Hunter G; Imoukhuede O; Kelly PJ; Kennedy J; Kenney C; Kleinig TJ; Krishnan K; Lima F; Mandzia JL; Marko M; Martins SO; Medvedev G; Menon BK; Mishra SM; Molina C; Moussaddy A; Muir KW; Parsons MW; Penn AMW; Pille A; Pontes-Neto OM; Roffe C; Serena J; Simister R; Singh N; Spratt N; Strbian D; Tham CH; Wiggam MI; Williams DJ; Willmot MR; Wu T; Yu AYX; Zachariah G; Zafar A; Zerna C; Hill MD;
Lancet; 2024 Jun; 403(10444):2597-2605. PubMed ID: 38768626
[TBL] [Abstract][Full Text] [Related]
8. Tenecteplase versus Alteplase before thrombectomy: A comprehensive evaluation of clinical and angiographic impact: Insights from the ETIS registry.
Zarzour A; Batot C; Boisseau W; Cho TH; Guillon B; Richard S; Marnat G; Arquizan C; Lapergue B; Weisenburger Lile D;
J Neuroradiol; 2024 Jun; 51(4):101189. PubMed ID: 38462131
[TBL] [Abstract][Full Text] [Related]
9. Comparative Analysis of Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Multicentric Observational Study from Eastern India.
Dutta A; Gupta S; Chakraborty U; Mondal C; Banerjee S; Das D; Jatua SK; Chakrabarty S; Misra S; Bhattacharya J; Datta SK; Ghosh S; Sanyal D; Sarkar A; Ray BK
Ann Indian Acad Neurol; 2024 May; 27(3):269-273. PubMed ID: 38819417
[TBL] [Abstract][Full Text] [Related]
10. Tenecteplase Versus Alteplase in Medium Vessel Occlusion Ischemic Stroke: A Secondary Analysis of the Alteplase Compared to Tenecteplase Randomized Trial.
Bala F; Singh N; Ignacio K; Alhabli I; Ademola A; Alrohimi A; Khosravani H; Tkach A; Catanese L; Dowlatshahi D; Field T; Hunter G; Benali F; Horn M; Demchuk A; Hill M; Sajobi T; Buck B; Swartz R; Almekhlafi M; Menon BK
J Stroke; 2024 May; 26(2):280-289. PubMed ID: 38836275
[TBL] [Abstract][Full Text] [Related]
11. Lack of Interactions Between Alteplase/Tenecteplase and the Adenosine A1R/A3R Agonist AST-004.
Liston TE; Holstein D; Solt D; Lozano D; Korinek WS; Lechleiter JD
Stroke; 2024 Jul; 55(7):1923-1926. PubMed ID: 38818720
[TBL] [Abstract][Full Text] [Related]
12. Tenecteplase versus alteplase for acute ischaemic stroke in the elderly patients: a post hoc analysis of the TRACE-2 trial.
Xiong Y; Wang L; Pan Y; Wang M; Schwamm LH; Duan C; Campbell BCV; Li S; Hao M; Wu N; Cao Z; Wu S; Li Z; Wang Y
Stroke Vasc Neurol; 2024 Jun; ():. PubMed ID: 38858097
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and safety among different doses of tenecteplase for acute ischemic stroke: A systematic review and network meta-analysis.
Srisurapanont K; Uawithya E; Dhanasomboon P; Pollasen N; Thiankhaw K
J Stroke Cerebrovasc Dis; 2024 Jun; 33(8):107822. PubMed ID: 38897370
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a Tenecteplase Protocol for Treatment of Acute Ischemic Stroke in a Health System.
Pace A; Wai M; Frye E
Innov Pharm; 2024; 15(1):. PubMed ID: 38779109
[No Abstract] [Full Text] [Related]
15. Tenecteplase Is a Better Alternative to Alteplase for Patients With Large Vessel Occlusion Stroke Receiving Bridging Therapy.
Song SS; Warach S
Neurology; 2024 Jul; 103(1):e209581. PubMed ID: 38865680
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of intravenous tenecteplase compared to alteplase before mechanical thrombectomy in acute ischemic stroke: a meta-analysis.
Wu N; Doeppner TR; Hermann DM; Gronewold J
J Neurol; 2024 May; ():. PubMed ID: 38782799
[TBL] [Abstract][Full Text] [Related]
17. Second-dose intravenous thrombolysis with tenecteplase in alteplase-resistant medium-vessel-occlusion strokes: A retrospective and comparative study.
Chausson N; Olindo S; Laborne FX; Aghasaryan M; Renou P; Soumah D; Debruxelles S; Altarcha T; Poli M; L'Hermitte Y; Sagnier S; Toudou-Daouda M; Aminou-Tassiou NR; Bentamra L; Benmoussa N; Alecu C; Imbernon C; Smadja L; Ouanounou G; Rouanet F; Sibon I; Smadja D
Eur Stroke J; 2024 Jun; ():23969873241254936. PubMed ID: 38829011
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in the Dual Antiplatelet Therapy Versus Alteplase for Patients with Minor Nondisabling Acute Ischemic Stroke: A Secondary Analysis of the ARAMIS Study.
Qu HL; Sun XY; He C; Chen HS
CNS Drugs; 2024 May; ():. PubMed ID: 38806883
[TBL] [Abstract][Full Text] [Related]
19. Use of Tenecteplase in Acute Ischemic Stroke in the Time of SARS-CoV-2.
Ostos F; Rodríguez-López A; Martin Jiménez P; Sánchez CS; Martínez-Salio A; Ballenilla F; Lizasoaín I; Calleja-Castaño P
Neurohospitalist; 2023 Jul; 13(3):266-271. PubMed ID: 37441211
[TBL] [Abstract][Full Text] [Related]
20. A bibliometric analysis of tenecteplase research utilizing a commonly used citation index.
Huang B; Libman R; Ballout A; DiUbaldi G; Arora R; Katz JM
Clin Neurol Neurosurg; 2024 Feb; 237():108170. PubMed ID: 38354425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
